Raber MN - Search Results

1

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Holmes FA, et al. Among authors: raber mn. J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805. doi: 10.1093/jnci/83.24.1797-a. J Natl Cancer Inst. 1991. PMID: 1683908 Clinical Trial.

2

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.

Hoffman K, Holmes FA, Fraschini G, Esparza L, Frye D, Raber MN, Newman RA, Hortobagyi GN. Hoffman K, et al. Among authors: raber mn. Cancer Chemother Pharmacol. 1996;37(3):254-8. doi: 10.1007/BF00688325. Cancer Chemother Pharmacol. 1996. PMID: 8529286 Clinical Trial.

3

Phase I/II clinical trial of didemnin B in non-small-cell lung cancer: neuromuscular toxicity is dose-limiting.

Shin DM, Holoye PY, Murphy WK, Forman A, Papasozomenos SC, Hong WK, Raber M. Shin DM, et al. Cancer Chemother Pharmacol. 1991;29(2):145-9. doi: 10.1007/BF00687325. Cancer Chemother Pharmacol. 1991. PMID: 1662119 Clinical Trial.

4

A phase II trial of taxol in metastatic melanoma.

Legha SS, Ring S, Papadopoulos N, Raber M, Benjamin RS. Legha SS, et al. Cancer. 1990 Jun 1;65(11):2478-81. doi: 10.1002/1097-0142(19900601)65:11<2478::aid-cncr2820651114>3.0.co;2-s. Cancer. 1990. PMID: 1970948

5

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer.

Benvenuto JA, Newman RA, Bignami GS, Raybould TJ, Raber MN, Esparza L, Walters RS. Benvenuto JA, et al. Among authors: raber mn. Invest New Drugs. 1992 Jul;10(2):113-7. doi: 10.1007/BF00873128. Invest New Drugs. 1992. PMID: 1500265 Clinical Trial.

6

Phase II clinical trial of didemnin B in previously treated small cell lung cancer.

Shin DM, Holoye PY, Forman A, Winn R, Perez-Soler R, Dakhil S, Rosenthal J, Raber MN, Hong WK. Shin DM, et al. Among authors: raber mn. Invest New Drugs. 1994;12(3):243-9. doi: 10.1007/BF00873966. Invest New Drugs. 1994. PMID: 7896544 Review.

7

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.

Murphy WK, Fossella FV, Winn RJ, Shin DM, Hynes HE, Gross HM, Davilla E, Leimert J, Dhingra H, Raber MN, et al. Murphy WK, et al. Among authors: raber mn. J Natl Cancer Inst. 1993 Mar 3;85(5):384-8. doi: 10.1093/jnci/85.5.384. J Natl Cancer Inst. 1993. PMID: 8094466 Clinical Trial.

8

Phase I clinical evaluation of [SP-4-3(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4- butanediamine-N,N1) platinum in patients with metastatic solid tumors.

Theriault RL, Cohen IA, Esparza L, Kowal C, Raber MN. Theriault RL, et al. Among authors: raber mn. Cancer Chemother Pharmacol. 1993;31(4):333-7. doi: 10.1007/BF00685681. Cancer Chemother Pharmacol. 1993. PMID: 8422699 Clinical Trial.

9

Intrapleural etoposide for malignant effusion.

Holoye PY, Jeffries DG, Dhingra HM, Holmes FA, Raber M, Engineer MS, Newman RA. Holoye PY, et al. Cancer Chemother Pharmacol. 1990;26(2):147-50. doi: 10.1007/BF02897262. Cancer Chemother Pharmacol. 1990. PMID: 2189591 Clinical Trial.

10

Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancer.

Abbruzzese JL, Weeks A, Raber MN, Gravel D, DuBrow RA, Levin B, Grem J, Chun HG. Abbruzzese JL, et al. Among authors: raber mn. J Natl Cancer Inst. 1989 Dec 6;81(23):1840-2. doi: 10.1093/jnci/81.23.1840. J Natl Cancer Inst. 1989. PMID: 2585532 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters